Changes in skeletal muscle and organ size after a weight-loss intervention in overweight and obese type 2 diabetic patients.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 27881389)

Published in Am J Clin Nutr on November 23, 2016

Authors

Dympna Gallagher1,2, David E Kelley3, John Thornton4, Lawrence Boxt5, Xavier Pi-Sunyer4,2, Edward Lipkin6, Ebenezer Nyenwe7, Isaiah Janumala4, Stanley Heshka4,2, MRI Ancillary Study Group of the Look AHEAD Research Group

Author Affiliations

1: New York Obesity Nutrition Research Center and dg108@columbia.edu.
2: Institute of Human Nutrition and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
3: Obesity and Nutrition Research Center, University of Pittsburgh, Pittsburgh, PA.
4: New York Obesity Nutrition Research Center and.
5: Department of Radiology, St. Luke's Hospital, New York, NY.
6: Division of Metabolism, University of Washington, Seattle, WA; and.
7: Division of Endocrinology Diabetes and Metabolism, University of Tennessee, Martin, TN.

Articles cited by this

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology (2004) 18.86

Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials (2003) 9.97

Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA (2008) 8.45

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes (2005) 5.22

Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med (1997) 4.26

One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring) (2009) 4.08

Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. Am J Physiol (1998) 3.65

Four-year weight losses in the Look AHEAD study: factors associated with long-term success. Obesity (Silver Spring) (2011) 3.62

Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Int J Obes (Lond) (2009) 2.32

Metabolic adaptation to caloric restriction and subsequent refeeding: the Minnesota Starvation Experiment revisited. Am J Clin Nutr (2015) 2.24

Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr (2009) 1.78

Small organs with a high metabolic rate explain lower resting energy expenditure in African American than in white adults. Am J Clin Nutr (2006) 1.48

The weight of the heart and its chambers in hypertensive cardiovascular disease with and without failure. Circulation (1953) 1.38

Larger mass of high-metabolic-rate organs does not explain higher resting energy expenditure in children. Am J Clin Nutr (2003) 1.37

Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes (2009) 1.23

Estimation of right ventricular mass in normal subjects and in patients with primary pulmonary hypertension by nuclear magnetic resonance imaging. J Am Coll Cardiol (1993) 1.15

Spleen enlargement in patients with nonalcoholic fatty liver: correlation between degree of fatty infiltration in liver and size of spleen. Dig Dis Sci (2000) 1.12

Weight loss composition is one-fourth fat-free mass: a critical review and critique of this widely cited rule. Obes Rev (2014) 1.09

Effect of weight loss and regain on adipose tissue distribution, composition of lean mass and resting energy expenditure in young overweight and obese adults. Int J Obes (Lond) (2013) 1.07

Brain and high metabolic rate organ mass: contributions to resting energy expenditure beyond fat-free mass. Am J Clin Nutr (2010) 1.06

Contribution of individual organ mass loss to weight loss-associated decline in resting energy expenditure. Am J Clin Nutr (2009) 1.05

Effects of moderate weight loss and orlistat on insulin resistance, regional adiposity, and fatty acids in type 2 diabetes. Diabetes Care (2004) 1.01

The size of the pancreas in diabetes mellitus. Diabet Med (1993) 1.01

Differential effect of weight loss on adipocyte size subfractions in patients with type 2 diabetes. Obesity (Silver Spring) (2009) 1.00

Impact of body composition during weight change on resting energy expenditure and homeostasis model assessment index in overweight nonsmoking adults. Am J Clin Nutr (2014) 0.94

Changes in body composition over 8 years in a randomized trial of a lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) (2015) 0.94

Effectiveness of weight loss interventions--is there a difference between men and women: a systematic review. Obes Rev (2014) 0.91

Size of the pancreas in non-insulin-dependent diabetic patients. J Med (1991) 0.88

Altered volume, morphology and composition of the pancreas in type 2 diabetes. PLoS One (2015) 0.85

Changes in adipose tissue depots and metabolic markers following a 1-year diet and exercise intervention in overweight and obese patients with type 2 diabetes. Diabetes Care (2014) 0.85

Skeletal muscle and organ masses differ in overweight adults with type 2 diabetes. J Appl Physiol (1985) (2014) 0.82

Sex differences in the composition of weight gain and loss in overweight and obese adults. Br J Nutr (2013) 0.81

Energy utilization and organ mass of Targhee sheep selected for rate and efficiency of gain and receiving high and low planes of nutrition. J Anim Sci (1991) 0.78

Articles by these authors

Adipose tissue distribution is different in type 2 diabetes. Am J Clin Nutr (2009) 1.78